Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

Ronald J. Bosch, Ronald T. Mitsuyasu, J. Michael Kilby, R. Pat Bucy, Donna Mildvan, Margaret A. Fischl, Jorge L. Santana, Jeffrey L. Lennox, Christopher D. Pilcher, Andrew R. Zolopa, Jody Lawrence, Richard B. Pollard, Rafaelle El-Habib, David Sahner, Lawrence Fox, Evgenia Aga. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).. Journal of Infectious Diseases. 2006. 194: 1672-6. PMID: 17109338

Year

2006

Journal

Journal of Infectious Diseases

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells

Tracey King, Lane R. Bushman, Jennifer J. Kiser, Peter Anderson, M. Graham Ray, Tom Delahunty, Courtney V. Fletcher. Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences. 2006. 843: 147-56.

Year

2006

Journal

Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences

HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml

Yumi Mitsuya, Mark A. Winters, W. Jeffrey Fessel, Soo-Yon Rhee, Sally Slome, Michael Horberg, Leo Hurley, Jason Flamm, Daniel Klein, Robert Shafer. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml. Journal of Acquired Immune Deficiency Syndromes. 2006. 43: 56-59.

Year

2006

Journal

Journal of Acquired Immune Deficiency Syndromes

A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086

Constance A. Benson, Florin Vaida, Diane V. Havlir, Gerald F. Downey, Michael M. Lederman, Roy (Trip) Gulick, Marshall Jay Glesby, Michael Wantman, Christian J. Bixby, Alex R. Rinehart, Sally Snyder, Rui Wang, Sheran Patel, John W. Mellors. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. Journal of Infectious Diseases. 2006. 194: 1309-18.

Year

2006

Journal

Journal of Infectious Diseases

Antibody responses to Hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy: P1008

Adriana Weinberg, Philimon Gona, Sharon Appelbaum Nachman, Patricia Alexandra Defechereux, Ram Yogev, Walter T. Hughes, Diane W. Wara, Carol Elgie, Marlene A. Cooper, Wayne M. Dankner. Antibody responses to Hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy: P1008. Journal of Infectious Diseases. 2006. 193: 302-311.

Year

2006

Journal

Journal of Infectious Diseases

Study

P1008

A history of pediatric immunology.

E. Richard Stiehm, Richard B. Johnston. A history of pediatric immunology.. Pediatric Research. 2006. 57: 458-467.

Year

2006

Journal

Pediatric Research

Play the Winner for Phase II/III Clinical Trials.

Qing Yao. Play the Winner for Phase II/III Clinical Trials.. Statistics In Medicine. 2006. 15: 2413-2423.

Year

2006

Journal

Statistics In Medicine